Pharmaceutical GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are prescription medications that have demonstrated significant effects in extensive clinical trials
It addresses five hallmarks of aging at once: telomere maintenance, epigenetic regulation, antioxidant defense via Nrf2, immune recalibration, and circadian rhythm restoration
Semaglutide itself interacts with the gut-brain axis through central GLP-1 receptors in the brain
Working out daily helps Studies on people with CKD recommend at least 150 minutes of moderate-intensity cardio per week, or at least 75 minutes of vigorous-intensity cardio, along with strength training of major muscle groups at least twice a week
Maintaining an anti-inflammatory diet, preserving muscle through resistance training, supporting bone health, and preparing for long-term maintenance can make a tremendous difference
Managing the transition period Regardless of direction, the 2 to 4 weeks around each switch are the highest-risk period